Croatia/Canada Begin Information Exchange On Pharma GMP Under EU Mutual Recognition Agreement
This article was originally published in SRA
Executive Summary
A mutual recognition agreement that allows Croatian drug agency HALMED and Health Canada to exchange information on good manufacturing practice requirements for medicinal products became operational on April 1. Under the agreement, the two agencies can now exchange information on marketing authorizations and safety of medicinal products, accept manufacturing licences as well as accept and exchange GMP certificates1.